Siamycins I and II, new anti-HIV-1 peptides: II. Sequence analysis and structure determination of siamycin I.
Detlefsen
D J
DJ
Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492, USA.
Hill
S E
SE
Volk
K J
KJ
Klohr
S E
SE
Tsunakawa
M
M
Furumai
T
T
Lin
P F
PF
Nishio
M
M
Kawano
K
K
Oki
T
T
D000595:Amino Acid Sequence; D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000494:pharmacology; D000998:Antiviral Agents / Q000737:chemistry* / Q000494:pharmacology; D015497:HIV-1 / Q000187:drug effects; D036341:Intercellular Signaling Peptides and Proteins; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D008969:Molecular Sequence Data; D015394:Molecular Structure; D010455:Peptides
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; C094260:siamycin I; C094261:siamycin II